Circles For Hospital-Employed Physicians and Researchers
December 14, 2023
Circles For Hospital-Employed Physicians and Researchers
![](https://cdn.prod.website-files.com/5f6e1c0200239d4debc07579/657af06dfb61b81319e9fd29_Website%20article.png)
Institutional constraints can limit the ability of physicians and researchers to collect long-term outcomes, design and execute studies, develop value-based care models best suited to their patient panels, or publish. Obstacles include time and RVU pressures, funding, complex IRB processes, and access to laboratory time and scientific experts.
Circles address these challenges. They inherently support collaboration across institutional and national borders. Their patented functionality is clinical grade, but imposes virtually no administrative burden. Cost is minimal; indeed, RegenMed often sources investigator-initiated study funding for Circle Members.
Circles thus represent a powerful yet efficient solution for observing, participating in, or even designing “external” real-world evidence initiatives.
Moreover, simple “internal” Circles implementations – such as long-term capture of standardized outcomes measures – can provide substantial clinical value to employed physicians. At only $5 per Case, and with easy data import capability for institutional EMRs, the cost-benefit analysis is straightforward.
Circles For Hospital-Employed Physicians and Researchers
December 14, 2023
![](https://cdn.prod.website-files.com/5f6e1c0200239d4debc07579/657af06dfb61b81319e9fd29_Website%20article.png)
Institutional constraints can limit the ability of physicians and researchers to collect long-term outcomes, design and execute studies, develop value-based care models best suited to their patient panels, or publish. Obstacles include time and RVU pressures, funding, complex IRB processes, and access to laboratory time and scientific experts.
Circles address these challenges. They inherently support collaboration across institutional and national borders. Their patented functionality is clinical grade, but imposes virtually no administrative burden. Cost is minimal; indeed, RegenMed often sources investigator-initiated study funding for Circle Members.
Circles thus represent a powerful yet efficient solution for observing, participating in, or even designing “external” real-world evidence initiatives.
Moreover, simple “internal” Circles implementations – such as long-term capture of standardized outcomes measures – can provide substantial clinical value to employed physicians. At only $5 per Case, and with easy data import capability for institutional EMRs, the cost-benefit analysis is straightforward.